Medicenna Therapeutics Corp. (TSX:MDNA)
Canada · Delayed Price · Currency is CAD 0.4500
+0.0100 (2.27%)
Nov 9, 2026, 4:00 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of CAD 41.54 million as of November 9, 2026. It is the 34,004th most valuable company in the world and the 1,003rd biggest in Canada. Its market cap has decreased by 65.66% in one year.
Market Cap
41.54M
Enterprise Value
35.95M
Revenue
n/a
Global Rank
Country Rank
#1,003 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has decreased from 65.63M to 41.54M, a decrease of -36.71%. That is a compound annual growth rate of -4.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 41.54M | -45.88% |
| Dec 31, 2025 | 76.75M | -40.53% |
| Dec 31, 2024 | 129.06M | 341.25% |
| Dec 29, 2023 | 29.25M | -34.38% |
| Dec 30, 2022 | 44.57M | -60.68% |
| Dec 31, 2021 | 113.36M | -62.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 48.64M |
| NurExone Biologic | 48.20M |
| Thiogenesis Therapeutics | 44.79M |
| Sharp Therapeutics | 43.26M |
| Sernova Biotherapeutics | 41.54M |
| Microbix Biosystems | 39.04M |
| Sona Nanotech | 36.23M |
| MedMira | 35.09M |